The overexpression of MTA1, achieved using the CRISPR activation plasmid, significantly promoted VM formation (Figure 3A–D), indicating that MTA1 is pivotal in facilitating VM in breast cancer cells. This evidence concerns the gene MTA1 and breast carcinoma.